DIAGNOS Enters the Retinal Diagnostics Market With its New

BROSSARD, Quebec, Oct. 27, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

Related Keywords

Mexico ,Saudi Arabia ,United States ,Canada ,Quebec ,Saudi ,Canadian ,Andre Larente ,Health Canada ,Artificial Intelligence ,Age Related Macular Degeneration ,Diabetic Retinopathy ,Macular Edema ,Retinal Cancer ,Computer Assisted Retina Analysis ,Tsx Venture Exchange Adk ,Iagnos Inc ,